By Debdeep Gupta | August, 14 2025
Anthem Bio shares surge 5 percent on strong show in CRDMO and specialty business
the company posted a consolidated revenue from operations at rs 540 crore, higher by 59 percent on year, and a net profit of rs 135.8 crore, up 65 percent on year. revenue from the crdmo business grew up 70 percent on year. anthem's ebitda rose by 52.7 percent to rs 214.3 crore.recently listed crdmo player anthem biosciences are sharply higher by nearly 5 percent after the company posted strong june quarter results.the company posted a consolidat